GlassScriptPhysician profile
Dennis Gordon Norem
NPI 1386754570
$1,866.42
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,390 · 2020: $100 · 2021: $360 · 2022: $16.97.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $714.75 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $227.77 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $148.08 | 2019 | |
| Sanofi-Aventis U.S. LLC | $125.00 | 2019 | |
| Pfizer INC. | $119.96 | 2019 | |
| Allergan, INC. | $100.00 | 2020 | |
| Novo Nordisk INC | $93.77 | 2019 | |
| Kci USA, INC. | $88.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.52 | 2019 | |
| Glaxosmithkline, LLC. | $73.51 | 2019 | |
| Lilly USA, LLC | $57.43 | 2019 | |
| Dexcom, INC. | $22.41 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.74 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Norem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.